{"brief_title": "A Phase 1 Study of S-3304 in Patients With Solid Tumors", "brief_summary": "To determine the maximum tolerated dose and safety profile of S-3304 in patients with biopsy accessible cancer who have failed previous therapy or to whom no standard therapies are available. To determine the pharmacokinetic profile of S-3304 in this patient population", "condition": "Solid Tumors", "intervention_type": "Drug", "intervention_name": "S-3304", "criteria": "Inclusion criteria: - Biopsy proven diagnosis of solid tumor(s) with biopsy accessible lesion(s) - Must be able to tolerate oral medication Exclusion criteria - Patients with other serious illnesses - Patients who are receiving treatments", "gender": "All", "minimum_age": "18 Years", "maximum_age": "85 Years", "healthy_volunteers": "No", "id": "NCT00033215.xml"}